Episode
Synthetic cells replicate in a dish & Universe may stay clumpy - News (Jul 2, 2026)
- Podcast
- The Automated Daily
- Published
- Jul 2, 2026
- Duration seconds
- 517
- Processing state
not_requested- Canonical source
- https://theautomateddaily.com/episodes/2026-07-02-synthetic-cells-replicate-in-a-dish-universe-may-stay-clumpy
Actions
POST https://stenobird.com/v1/public/podcasts/the-automated-daily-6466996/episodes/synthetic-cells-replicate-in-a-dish-universe-may-stay-clumpy-news-jul-2-2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-automated-daily-6466996/synthetic-cells-replicate-in-a-dish-universe-may-stay-clumpy-news-jul-2-2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Please support this podcast by checking out our sponsors: - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Synthetic cells replicate in a dish - University of Minnesota “SpudCells” show a lab-built synthetic cell cycle—growth, DNA copying, and division—using liposomes and synthetic DNA, raising big origin-of-life questions. Universe may stay clumpy - DESI galaxy-mapping data suggests large-scale structure may remain directionally aligned over billions of light years, challenging the cosmological principle and testing ΛCDM assumptions. Supersonic flights inch back - The FAA is moving from an outright overland Mach 1 ban toward a noise-based rule, reopening the possibility of quieter supersonic passenger routes if communities can be protected from booms. Payments giants launch stablecoin network - Visa, Mastercard, and Coinbase-backed Open Standard plans a dollar-pegged stablecoin for mainstream payments, boosted by new U.S. rules emphasizing 1:1 reserves and AML safeguards. New angles on immunotherapy for glioblastoma - A Nature study targets glioblastoma’s tumor ecosystem with CAR-T cells aimed at GPNMB, potentially hitting both cancer cells and immunosuppressive macrophages to reduce recurrence risk. mRNA vaccines safety and next uses - A Lancet review finds Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines remained safe and effective through 2025 data, while spotlighting future mRNA applications like personalized cancer vaccines. NASA speeds up lunar base plans - NASA awar…